欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/3843/001
药品名称Ebetrex
活性成分
    • methotrexate 20.0 mg
剂型Solution for injection
上市许可持有人Sandoz Pharmaceuticals GmbH Raiffeisenstr. 11 D-83607 Holzkirchen Germany
参考成员国 - 产品名称Netherlands (NL)
Ebetrex
互认成员国 - 产品名称
    • Denmark (DK)
    • Austria (AT)
      Ebetrexat 20 mg/ml Injektionslösung in einer Fertigspritze
    • Sweden (SE)
      Ebetrex
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
      Ebetrexat 20 mg/ml injekcinis tirpalas užpildytame švirkšte
    • Estonia (EE)
    • Hungary (HU)
      EBETREXAT 20 mg/ml oldatos injekció előretöltött fecskendőben
    • Bulgaria (BG)
      Ebetrexat
    • Romania (RO)
      Methrotrexate Ebewe 20 mg/ml solutie injectabilă în seringa preumplută
    • Slovakia (SK)
      Methotrexat Ebewe 20 mg/ml
    • Slovenia (SI)
    • United Kingdom (Northern Ireland) (XI)
    • Spain (ES)
许可日期2009/03/16
最近更新日期2023/11/22
药物ATC编码
    • M01CX Other specific antirheumatic agents
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase